back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-01-13 16:19 Tx date 2023-10-21 |
$ATE
Antibe Therapeutics Inc. |
Macnee, Walter Minnes
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-7,500 vol |
65,000 | |
| Filed 2023-09-15 18:11 Tx date 2023-09-12 |
$ATE
Antibe Therapeutics Inc. |
Macnee, Walter Minnes
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+15,000 vol |
72,500 | |
| Filed 2022-11-19 12:35 Tx date 2022-11-15 |
$ATE
Antibe Therapeutics Inc. |
Macnee, Walter Minnes
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+5,000 vol |
57,500 | |
| Filed 2022-07-13 13:50 Tx date 2022-06-16 |
$ATE
Antibe Therapeutics Inc. |
Macnee, Walter Minnes
4 - Director of Issuer
Direct Ownership
|
Warrants
38 - Redemption, retraction, cancellation, repurchase
|
-8,333 vol |
0 | |
| Filed 2021-12-01 23:30 Tx date 2021-11-29 |
$ATE
Antibe Therapeutics Inc. |
Macnee, Walter Minnes
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+5,333 vol |
502,360 | |
| Filed 2021-12-01 23:29 Tx date 2021-11-29 |
$ATE
Antibe Therapeutics Inc. |
Macnee, Walter Minnes
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-5,333 vol |
50,334 | |
| Filed 2021-11-19 20:15 Tx date 2021-11-15 |
$ATE
Antibe Therapeutics Inc. |
Macnee, Walter Minnes
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+5,000 vol |
55,667 | |
| Filed 2021-11-16 14:21 Tx date 2021-11-10 |
$ATE
Antibe Therapeutics Inc. |
Macnee, Walter Minnes
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$45,000
+50,000 vol $0.90 each |
497,027 | |
| Filed 2021-11-07 18:59 Tx date 2021-11-03 |
$ATE
Antibe Therapeutics Inc. |
Macnee, Walter Minnes
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$24,385
+25,000 vol $0.98 each |
447,027 | |
| Filed 2021-11-02 11:33 Tx date 2021-11-01 |
$ATE
Antibe Therapeutics Inc. |
Macnee, Walter Minnes
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$23,500
+25,000 vol $0.94 each |
422,027 | |
| Filed 2021-10-13 17:10 Tx date 2021-10-04 |
$ATE
Antibe Therapeutics Inc. |
Macnee, Walter Minnes
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+12,000 vol |
397,027 | |
| Filed 2021-10-13 17:08 Tx date 2021-10-04 |
$ATE
Antibe Therapeutics Inc. |
Macnee, Walter Minnes
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-12,000 vol |
50,667 | |
| Filed 2021-06-06 15:55 Tx date 2021-06-03 |
$ATE
Antibe Therapeutics Inc. |
Macnee, Walter Minnes
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-400,300
-100,000 vol $4.00 each |
385,027 | |
| Filed 2021-01-15 18:47 Tx date 2021-01-11 |
$ATE
Antibe Therapeutics Inc. |
Macnee, Walter Minnes
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+40,000 vol |
62,667 | |
| Filed 2020-12-17 18:28 Tx date 2020-12-01 |
$ATE
Antibe Therapeutics Inc. |
Macnee, Walter Minnes
4 - Director of Issuer
Direct Ownership
|
Warrants
37 - Stock split or consolidation
|
-75,000 vol |
8,333 | |
| Filed 2020-12-17 18:27 Tx date 2020-12-01 |
$ATE
Antibe Therapeutics Inc. |
Macnee, Walter Minnes
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
37 - Stock split or consolidation
|
-204,000 vol |
22,667 | |
| Filed 2020-12-17 18:26 Tx date 2020-12-01 |
$ATE
Antibe Therapeutics Inc. |
Macnee, Walter Minnes
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-472,500 vol |
52,500 | |
| Filed 2020-12-17 18:25 Tx date 2020-12-01 |
$ATE
Antibe Therapeutics Inc. |
Macnee, Walter Minnes
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-4,365,240 vol |
485,027 | |
| Filed 2020-12-17 14:47 Tx date 2020-11-30 |
$ATE
Antibe Therapeutics Inc. |
Macnee, Walter Minnes
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+53,333 vol |
4,850,267 | |
| Filed 2020-12-17 14:46 Tx date 2020-11-30 |
$ATE
Antibe Therapeutics Inc. |
Macnee, Walter Minnes
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-53,333 vol |
226,667 | |
| Filed 2020-10-08 22:40 Tx date 2020-10-05 |
$ATE
Antibe Therapeutics Inc. |
Macnee, Walter Minnes
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+120,000 vol |
4,796,934 | |
| Filed 2020-10-08 22:38 Tx date 2020-10-05 |
$ATE
Antibe Therapeutics Inc. |
Macnee, Walter Minnes
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-120,000 vol |
280,000 | |
| Filed 2020-04-09 13:31 Tx date 2020-04-09 |
$
Klinik Health Ventures Corp. |
Macnee, Walter Minnes
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+89,958 vol |
322,458 | |
| Filed 2019-12-06 09:46 Tx date 2019-12-03 |
$
Klinik Health Ventures Corp. |
Macnee, Walter Minnes
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+232,500 vol |
232,500 | |
| Filed 2019-12-06 09:44 Tx date 2019-11-26 |
$
Klinik Health Ventures Corp. |
Macnee, Walter Minnes
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-12-06 09:43 Tx date 2019-11-26 |
$
Klinik Health Ventures Corp. |
Macnee, Walter Minnes
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
897,500 | ||
| Filed 2019-11-28 12:56 Tx date 2019-11-28 |
$ATE
Antibe Therapeutics Inc. |
Macnee, Walter Minnes
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+160,000 vol |
400,000 | |
| Filed 2019-10-10 16:01 Tx date 2019-10-03 |
$ATE
Antibe Therapeutics Inc. |
Macnee, Walter Minnes
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+120,000 vol |
4,676,934 | |
| Filed 2019-10-10 15:59 Tx date 2019-10-03 |
$ATE
Antibe Therapeutics Inc. |
Macnee, Walter Minnes
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-120,000 vol |
240,000 | |
| Filed 2019-08-13 14:31 Tx date 2019-08-13 |
$ATE
Antibe Therapeutics Inc. |
Macnee, Walter Minnes
4 - Director of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
$24,999
+83,333 vol $0.30 each |
83,333 | |
| Filed 2019-08-13 14:25 Tx date 2019-08-13 |
$ATE
Antibe Therapeutics Inc. |
Macnee, Walter Minnes
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$50,000
+166,667 vol $0.30 each |
4,556,934 | |
| Filed 2019-06-03 12:18 Tx date 2019-06-01 |
$ATE
Antibe Therapeutics Inc. |
Macnee, Walter Minnes
4 - Director of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
-120,000 vol |
0 | |
| Filed 2018-10-05 Tx date 2013-06-10 |
$ATE
Antibe Therapeutics Inc. |
Macnee, Walter Minnes
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-10-05 Tx date 2018-10-03 |
$ATE
Antibe Therapeutics Inc. |
Macnee, Walter Minnes
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
97 - Other
|
+360,000 vol |
360,000 | |
| Filed 2018-10-02 Tx date 2018-09-28 |
$ATE
Antibe Therapeutics Inc. |
Macnee, Walter Minnes
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$51,000
+150,000 vol $0.34 each |
4,390,267 | |
| Filed 2018-03-26 Tx date 2018-03-23 |
$ATE
Antibe Therapeutics Inc. |
Macnee, Walter Minnes
4 - Director of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$171,750
+1,145,000 vol $0.15 each |
4,240,267 | |
| Filed 2018-03-26 Tx date 2018-03-23 |
$ATE
Antibe Therapeutics Inc. |
Macnee, Walter Minnes
4 - Director of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$-171,750
-1,145,000 vol $0.15 each |
120,000 | |
| Filed 2018-03-25 Tx date 2017-12-01 |
$ATE
Antibe Therapeutics Inc. |
Macnee, Walter Minnes
4 - Director of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
-150,000 vol |
1,265,000 | |
| Filed 2018-03-25 Tx date 2017-12-01 |
$ATE
Antibe Therapeutics Inc. |
Macnee, Walter Minnes
4 - Director of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
-150,000 vol |
||
| Filed 2018-03-23 Tx date 2017-12-01 |
$ATE
Antibe Therapeutics Inc. |
Macnee, Walter Minnes
4 - Director of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
-150,000 vol |
1,265,000 | |
| Filed 2017-04-03 Tx date 2017-03-31 |
$ATE
Antibe Therapeutics Inc. |
Macnee, Walter Minnes
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$40,000
+200,000 vol $0.20 each |
525,000 | |
| Filed 2016-06-14 Tx date 2016-06-10 |
$ATE
Antibe Therapeutics Inc. |
Macnee, Walter Minnes
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$100,000
+1,000,000 vol $0.10 each |
3,095,267 | |
| Filed 2016-06-14 Tx date 2016-06-10 |
$ATE
Antibe Therapeutics Inc. |
Macnee, Walter Minnes
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$50,000
+500,000 vol $0.10 each |
1,415,000 | |
| Filed 2016-03-11 Tx date 2016-03-09 |
$ATE
Antibe Therapeutics Inc. |
Macnee, Walter Minnes
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$36,250
+250,000 vol $0.145 each |
325,000 |